A detailed history of Birch Financial Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Birch Financial Group, LLC holds 439 shares of LLY stock, worth $448,526. This represents 0.27% of its overall portfolio holdings.

Number of Shares
439
Previous 1,425 69.19%
Holding current value
$448,526
Previous $1.09 Billion 56.59%
% of portfolio
0.27%
Previous 0.64%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 15, 2026

SELL
$799.57 - $1025.28 $788,376 - $1.01 Million
-986 Reduced 69.19%
439 $472 Million
Q3 2025

Oct 30, 2025

BUY
$625.65 - $812.69 $142,022 - $184,480
227 Added 18.95%
1,425 $1.09 Billion
Q2 2025

Oct 30, 2025

BUY
$713.71 - $898.95 $47,104 - $59,330
66 Added 5.83%
1,198 $934 Million
Q1 2025

Oct 30, 2025

BUY
$725.72 - $929.72 $406,403 - $520,643
560 Added 97.9%
1,132 $935 Million
Q4 2024

Oct 30, 2025

BUY
$727.2 - $932.06 $415,958 - $533,138
572 New
572 $442 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Birch Financial Group, LLC Portfolio

Follow Birch Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birch Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Birch Financial Group, LLC with notifications on news.